ANGO
ANGO
NASDAQ · Health Care

Angiodynamics Inc

$10.98
+0.11 (+1.01%)
Financial Highlights (FY 2026)
Revenue
292.74M
Net Income
-34,022,123
Gross Margin
53.9%
Profit Margin
-11.6%
Rev Growth
-2.6%
D/E Ratio
0.03
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 53.9% 53.9% 30.9% 30.9%
Operating Margin -13.7% -12.3% 21.0% 18.9%
Profit Margin -11.6% -11.0% 17.3% 13.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 292.74M 300.43M 101.13M 92.93M
Gross Profit 157.85M 161.99M 31.21M 28.68M
Operating Income -39,988,718 -36,935,392 21.24M 17.55M
Net Income -34,022,123 -31,424,374 17.51M 12.74M
Gross Margin 53.9% 53.9% 30.9% 30.9%
Operating Margin -13.7% -12.3% 21.0% 18.9%
Profit Margin -11.6% -11.0% 17.3% 13.7%
Rev Growth -2.6% -2.6% +21.6% +13.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 7.53M 7.53M 20.80M 26.73M
Total Equity 222.05M 222.05M 316.66M 268.59M
D/E Ratio 0.03 0.03 0.07 0.10
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -24,712,139 -24,093,321 29.28M 26.49M
Free Cash Flow 17.77M 16.03M